nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—VEGFA—polycystic ovary syndrome	0.643	1	CbGaD
Minocycline—CASP3—ovarian follicle—polycystic ovary syndrome	0.0258	0.171	CbGeAlD
Minocycline—MMP9—tunica intima—polycystic ovary syndrome	0.0146	0.097	CbGeAlD
Minocycline—CYCS—embryo—polycystic ovary syndrome	0.00408	0.0271	CbGeAlD
Minocycline—SLC22A8—urine—polycystic ovary syndrome	0.00385	0.0255	CbGeAlD
Minocycline—CASP3—embryo—polycystic ovary syndrome	0.00349	0.0232	CbGeAlD
Minocycline—CASP1—endometrium—polycystic ovary syndrome	0.0031	0.0206	CbGeAlD
Minocycline—CASP3—adrenal cortex—polycystic ovary syndrome	0.00286	0.019	CbGeAlD
Minocycline—CASP1—uterus—polycystic ovary syndrome	0.00286	0.019	CbGeAlD
Minocycline—CASP1—pituitary gland—polycystic ovary syndrome	0.0028	0.0186	CbGeAlD
Minocycline—CASP1—adipose tissue—polycystic ovary syndrome	0.00279	0.0185	CbGeAlD
Minocycline—IL1B—embryo—polycystic ovary syndrome	0.00279	0.0185	CbGeAlD
Minocycline—CYCS—uterus—polycystic ovary syndrome	0.00275	0.0182	CbGeAlD
Minocycline—CASP3—endometrium—polycystic ovary syndrome	0.00255	0.017	CbGeAlD
Minocycline—CASP1—adrenal gland—polycystic ovary syndrome	0.0025	0.0166	CbGeAlD
Minocycline—CYCS—adrenal gland—polycystic ovary syndrome	0.00241	0.016	CbGeAlD
Minocycline—CASP3—uterus—polycystic ovary syndrome	0.00235	0.0156	CbGeAlD
Minocycline—CASP1—female gonad—polycystic ovary syndrome	0.00234	0.0155	CbGeAlD
Minocycline—MMP9—embryo—polycystic ovary syndrome	0.00232	0.0154	CbGeAlD
Minocycline—CASP1—vagina—polycystic ovary syndrome	0.00232	0.0154	CbGeAlD
Minocycline—CASP3—pituitary gland—polycystic ovary syndrome	0.00231	0.0153	CbGeAlD
Minocycline—CASP3—adipose tissue—polycystic ovary syndrome	0.0023	0.0153	CbGeAlD
Minocycline—CYCS—female gonad—polycystic ovary syndrome	0.00225	0.0149	CbGeAlD
Minocycline—VEGFA—adrenal cortex—polycystic ovary syndrome	0.00225	0.0149	CbGeAlD
Minocycline—CASP1—endocrine gland—polycystic ovary syndrome	0.00217	0.0144	CbGeAlD
Minocycline—CYCS—endocrine gland—polycystic ovary syndrome	0.00209	0.0139	CbGeAlD
Minocycline—CASP3—adrenal gland—polycystic ovary syndrome	0.00207	0.0137	CbGeAlD
Minocycline—IL1B—endometrium—polycystic ovary syndrome	0.00204	0.0135	CbGeAlD
Minocycline—VEGFA—endometrium—polycystic ovary syndrome	0.00201	0.0133	CbGeAlD
Minocycline—CASP3—female gonad—polycystic ovary syndrome	0.00193	0.0128	CbGeAlD
Minocycline—CASP3—vagina—polycystic ovary syndrome	0.00191	0.0127	CbGeAlD
Minocycline—IL1B—uterus—polycystic ovary syndrome	0.00188	0.0125	CbGeAlD
Minocycline—VEGFA—uterus—polycystic ovary syndrome	0.00185	0.0123	CbGeAlD
Minocycline—IL1B—pituitary gland—polycystic ovary syndrome	0.00185	0.0123	CbGeAlD
Minocycline—IL1B—adipose tissue—polycystic ovary syndrome	0.00184	0.0122	CbGeAlD
Minocycline—VEGFA—pituitary gland—polycystic ovary syndrome	0.00182	0.0121	CbGeAlD
Minocycline—VEGFA—adipose tissue—polycystic ovary syndrome	0.00181	0.012	CbGeAlD
Minocycline—CASP3—endocrine gland—polycystic ovary syndrome	0.00179	0.0119	CbGeAlD
Minocycline—MMP9—endometrium—polycystic ovary syndrome	0.0017	0.0113	CbGeAlD
Minocycline—IL1B—adrenal gland—polycystic ovary syndrome	0.00165	0.011	CbGeAlD
Minocycline—VEGFA—adrenal gland—polycystic ovary syndrome	0.00162	0.0108	CbGeAlD
Minocycline—MMP9—uterus—polycystic ovary syndrome	0.00157	0.0104	CbGeAlD
Minocycline—IL1B—female gonad—polycystic ovary syndrome	0.00154	0.0102	CbGeAlD
Minocycline—MMP9—adipose tissue—polycystic ovary syndrome	0.00153	0.0102	CbGeAlD
Minocycline—IL1B—vagina—polycystic ovary syndrome	0.00153	0.0101	CbGeAlD
Minocycline—VEGFA—female gonad—polycystic ovary syndrome	0.00151	0.01	CbGeAlD
Minocycline—VEGFA—vagina—polycystic ovary syndrome	0.0015	0.00998	CbGeAlD
Minocycline—IL1B—endocrine gland—polycystic ovary syndrome	0.00143	0.0095	CbGeAlD
Minocycline—MMP9—adrenal gland—polycystic ovary syndrome	0.00137	0.00913	CbGeAlD
Minocycline—MMP9—female gonad—polycystic ovary syndrome	0.00128	0.00851	CbGeAlD
Minocycline—ALOX5—adipose tissue—polycystic ovary syndrome	0.00121	0.00804	CbGeAlD
Minocycline—MMP9—endocrine gland—polycystic ovary syndrome	0.00119	0.00791	CbGeAlD
Minocycline—SLC22A11—endocrine gland—polycystic ovary syndrome	0.00113	0.0075	CbGeAlD
Minocycline—SLC22A7—endocrine gland—polycystic ovary syndrome	0.0011	0.00732	CbGeAlD
Minocycline—ALOX5—adrenal gland—polycystic ovary syndrome	0.00109	0.00722	CbGeAlD
Minocycline—ALOX5—female gonad—polycystic ovary syndrome	0.00101	0.00673	CbGeAlD
Minocycline—ALOX5—endocrine gland—polycystic ovary syndrome	0.000943	0.00626	CbGeAlD
Minocycline—VEGFA—Developmental Biology—ADIPOQ—polycystic ovary syndrome	6.17e-05	0.000299	CbGpPWpGaD
Minocycline—CYCS—Metabolism—NAMPT—polycystic ovary syndrome	6.16e-05	0.000299	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—FSHR—polycystic ovary syndrome	6.12e-05	0.000297	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CYP11A1—polycystic ovary syndrome	6.09e-05	0.000295	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NPB—polycystic ovary syndrome	6.04e-05	0.000293	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—IGF1—polycystic ovary syndrome	6.02e-05	0.000292	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—AKT2—polycystic ovary syndrome	6.02e-05	0.000292	CbGpPWpGaD
Minocycline—IL1B—Immune System—GAB1—polycystic ovary syndrome	5.98e-05	0.00029	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	5.97e-05	0.000289	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—BCL2—polycystic ovary syndrome	5.93e-05	0.000288	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—IL6—polycystic ovary syndrome	5.92e-05	0.000287	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	5.91e-05	0.000286	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—BCL2—polycystic ovary syndrome	5.86e-05	0.000284	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—SLC2A4—polycystic ovary syndrome	5.82e-05	0.000282	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PTGER3—polycystic ovary syndrome	5.8e-05	0.000281	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—LHCGR—polycystic ovary syndrome	5.8e-05	0.000281	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL18—polycystic ovary syndrome	5.78e-05	0.00028	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	5.77e-05	0.00028	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—RACGAP1—polycystic ovary syndrome	5.75e-05	0.000279	CbGpPWpGaD
Minocycline—CYCS—Metabolism—AKR1C3—polycystic ovary syndrome	5.75e-05	0.000279	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—SERPINE1—polycystic ovary syndrome	5.72e-05	0.000277	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—SERPINE1—polycystic ovary syndrome	5.72e-05	0.000277	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CYP17A1—polycystic ovary syndrome	5.66e-05	0.000274	CbGpPWpGaD
Minocycline—CASP1—Immune System—NRG1—polycystic ovary syndrome	5.65e-05	0.000274	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	5.63e-05	0.000273	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ADRA1A—polycystic ovary syndrome	5.6e-05	0.000271	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—HMMR—polycystic ovary syndrome	5.59e-05	0.000271	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	5.46e-05	0.000265	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—FST—polycystic ovary syndrome	5.45e-05	0.000264	CbGpPWpGaD
Minocycline—IL1B—Immune System—CAMK2D—polycystic ovary syndrome	5.43e-05	0.000263	CbGpPWpGaD
Minocycline—IL1B—Myometrial Relaxation and Contraction Pathways—IL6—polycystic ovary syndrome	5.43e-05	0.000263	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PTAFR—polycystic ovary syndrome	5.43e-05	0.000263	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—IL6—polycystic ovary syndrome	5.41e-05	0.000262	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	5.4e-05	0.000262	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ADRB3—polycystic ovary syndrome	5.39e-05	0.000261	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—NCOR1—polycystic ovary syndrome	5.36e-05	0.00026	CbGpPWpGaD
Minocycline—IL1B—Immune System—TNRC6B—polycystic ovary syndrome	5.35e-05	0.000259	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—HSD3B1—polycystic ovary syndrome	5.33e-05	0.000258	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—LHB—polycystic ovary syndrome	5.32e-05	0.000258	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	5.28e-05	0.000256	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ADRA1D—polycystic ovary syndrome	5.27e-05	0.000255	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	5.27e-05	0.000255	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	5.23e-05	0.000254	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—GNRH1—polycystic ovary syndrome	5.2e-05	0.000252	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—IL6—polycystic ovary syndrome	5.18e-05	0.000251	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ADRA1B—polycystic ovary syndrome	5.13e-05	0.000248	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—AKR1C1—polycystic ovary syndrome	5.04e-05	0.000244	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PTGER3—polycystic ovary syndrome	5.04e-05	0.000244	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—LHCGR—polycystic ovary syndrome	5.04e-05	0.000244	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—INHBB—polycystic ovary syndrome	5e-05	0.000242	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	5e-05	0.000242	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—SCT—polycystic ovary syndrome	4.99e-05	0.000242	CbGpPWpGaD
Minocycline—CYCS—Metabolism—TH—polycystic ovary syndrome	4.9e-05	0.000237	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—IL6—polycystic ovary syndrome	4.86e-05	0.000236	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—LHB—polycystic ovary syndrome	4.86e-05	0.000236	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—IL6—polycystic ovary syndrome	4.85e-05	0.000235	CbGpPWpGaD
Minocycline—CASP1—Immune System—IRS2—polycystic ovary syndrome	4.84e-05	0.000235	CbGpPWpGaD
Minocycline—CASP1—Immune System—CRP—polycystic ovary syndrome	4.84e-05	0.000235	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—GNAS—polycystic ovary syndrome	4.79e-05	0.000232	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	4.79e-05	0.000232	CbGpPWpGaD
Minocycline—CYCS—Metabolism—SLC2A4—polycystic ovary syndrome	4.76e-05	0.000231	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MTNR1B—polycystic ovary syndrome	4.76e-05	0.000231	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—HSD3B2—polycystic ovary syndrome	4.75e-05	0.00023	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	4.73e-05	0.000229	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PTAFR—polycystic ovary syndrome	4.71e-05	0.000228	CbGpPWpGaD
Minocycline—IL1B—Immune System—ATF1—polycystic ovary syndrome	4.69e-05	0.000228	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—FGF18—polycystic ovary syndrome	4.68e-05	0.000227	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PDE3B—polycystic ovary syndrome	4.66e-05	0.000226	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—NCOR1—polycystic ovary syndrome	4.66e-05	0.000226	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—RBP4—polycystic ovary syndrome	4.64e-05	0.000225	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—AKR1C1—polycystic ovary syndrome	4.6e-05	0.000223	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—IL6—polycystic ovary syndrome	4.59e-05	0.000222	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ADRA1D—polycystic ovary syndrome	4.57e-05	0.000222	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—IL6—polycystic ovary syndrome	4.49e-05	0.000218	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CYP19A1—polycystic ovary syndrome	4.48e-05	0.000217	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ADRA1B—polycystic ovary syndrome	4.45e-05	0.000216	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	4.43e-05	0.000215	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—LEP—polycystic ovary syndrome	4.41e-05	0.000214	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	4.4e-05	0.000213	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—INHBB—polycystic ovary syndrome	4.34e-05	0.00021	CbGpPWpGaD
Minocycline—IL1B—Immune System—TAB1—polycystic ovary syndrome	4.33e-05	0.00021	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—YAP1—polycystic ovary syndrome	4.33e-05	0.00021	CbGpPWpGaD
Minocycline—IL1B—Immune System—PRL—polycystic ovary syndrome	4.29e-05	0.000208	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—GAB1—polycystic ovary syndrome	4.27e-05	0.000207	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FSHR—polycystic ovary syndrome	4.25e-05	0.000206	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—SULT2A1—polycystic ovary syndrome	4.23e-05	0.000205	CbGpPWpGaD
Minocycline—CASP1—Immune System—IRS1—polycystic ovary syndrome	4.22e-05	0.000205	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—RRM2—polycystic ovary syndrome	4.1e-05	0.000199	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—INSR—polycystic ovary syndrome	4.08e-05	0.000198	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PDE3B—polycystic ovary syndrome	4.05e-05	0.000196	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	4.02e-05	0.000195	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	4.02e-05	0.000195	CbGpPWpGaD
Minocycline—CYCS—Metabolism—GNAS—polycystic ovary syndrome	4e-05	0.000194	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—RACGAP1—polycystic ovary syndrome	3.99e-05	0.000194	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—YAP1—polycystic ovary syndrome	3.95e-05	0.000192	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	3.95e-05	0.000191	CbGpPWpGaD
Minocycline—CASP1—Immune System—AKT2—polycystic ovary syndrome	3.91e-05	0.00019	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ADRA1A—polycystic ovary syndrome	3.88e-05	0.000188	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—AKR1C3—polycystic ovary syndrome	3.88e-05	0.000188	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—PPARG—polycystic ovary syndrome	3.84e-05	0.000186	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—LEP—polycystic ovary syndrome	3.83e-05	0.000186	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TNRC6B—polycystic ovary syndrome	3.82e-05	0.000185	CbGpPWpGaD
Minocycline—CYCS—Metabolism—NCOR1—polycystic ovary syndrome	3.81e-05	0.000185	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—NAMPT—polycystic ovary syndrome	3.8e-05	0.000184	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FST—polycystic ovary syndrome	3.79e-05	0.000184	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PGR—polycystic ovary syndrome	3.78e-05	0.000183	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	3.78e-05	0.000183	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—INS—polycystic ovary syndrome	3.77e-05	0.000183	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CYP11A1—polycystic ovary syndrome	3.75e-05	0.000182	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ADRB3—polycystic ovary syndrome	3.74e-05	0.000181	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	3.72e-05	0.000181	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—LHB—polycystic ovary syndrome	3.7e-05	0.000179	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FSHR—polycystic ovary syndrome	3.69e-05	0.000179	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—IL6—polycystic ovary syndrome	3.67e-05	0.000178	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	3.67e-05	0.000178	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—AKT2—polycystic ovary syndrome	3.64e-05	0.000177	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GNRH1—polycystic ovary syndrome	3.61e-05	0.000175	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL18—polycystic ovary syndrome	3.61e-05	0.000175	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CYP1A1—polycystic ovary syndrome	3.61e-05	0.000175	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	3.6e-05	0.000174	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—AKR1C3—polycystic ovary syndrome	3.54e-05	0.000172	CbGpPWpGaD
Minocycline—IL1B—Immune System—NRG1—polycystic ovary syndrome	3.53e-05	0.000171	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PLAT—polycystic ovary syndrome	3.51e-05	0.00017	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—GHRL—polycystic ovary syndrome	3.51e-05	0.00017	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—AKR1C1—polycystic ovary syndrome	3.5e-05	0.00017	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CYP17A1—polycystic ovary syndrome	3.49e-05	0.000169	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—RACGAP1—polycystic ovary syndrome	3.47e-05	0.000168	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SCT—polycystic ovary syndrome	3.46e-05	0.000168	CbGpPWpGaD
Minocycline—CASP1—Immune System—BCL2—polycystic ovary syndrome	3.42e-05	0.000166	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—IL6—polycystic ovary syndrome	3.38e-05	0.000164	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	3.38e-05	0.000164	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ADRA1A—polycystic ovary syndrome	3.37e-05	0.000163	CbGpPWpGaD
Minocycline—CYCS—Metabolism—MTHFR—polycystic ovary syndrome	3.37e-05	0.000163	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	3.36e-05	0.000163	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ATF1—polycystic ovary syndrome	3.35e-05	0.000163	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—VEGFA—polycystic ovary syndrome	3.34e-05	0.000162	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—PPARG—polycystic ovary syndrome	3.34e-05	0.000162	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MTNR1B—polycystic ovary syndrome	3.3e-05	0.00016	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FST—polycystic ovary syndrome	3.29e-05	0.000159	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—INS—polycystic ovary syndrome	3.27e-05	0.000159	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TCF7L2—polycystic ovary syndrome	3.27e-05	0.000158	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ADRB3—polycystic ovary syndrome	3.25e-05	0.000157	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FGF18—polycystic ovary syndrome	3.25e-05	0.000157	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—RBP4—polycystic ovary syndrome	3.22e-05	0.000156	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—LHB—polycystic ovary syndrome	3.21e-05	0.000155	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—AKT2—polycystic ovary syndrome	3.16e-05	0.000153	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GNRH1—polycystic ovary syndrome	3.14e-05	0.000152	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—IGF1—polycystic ovary syndrome	3.11e-05	0.000151	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—AKT2—polycystic ovary syndrome	3.1e-05	0.00015	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NGFR—polycystic ovary syndrome	3.09e-05	0.00015	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PRL—polycystic ovary syndrome	3.07e-05	0.000149	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—AKR1C1—polycystic ovary syndrome	3.04e-05	0.000147	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—IL6—polycystic ovary syndrome	3.04e-05	0.000147	CbGpPWpGaD
Minocycline—IL1B—Immune System—IRS2—polycystic ovary syndrome	3.02e-05	0.000147	CbGpPWpGaD
Minocycline—IL1B—Immune System—CRP—polycystic ovary syndrome	3.02e-05	0.000147	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—TH—polycystic ovary syndrome	3.02e-05	0.000146	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SCT—polycystic ovary syndrome	3.01e-05	0.000146	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—YAP1—polycystic ovary syndrome	3.01e-05	0.000146	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GAB1—polycystic ovary syndrome	2.96e-05	0.000144	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—SERPINE1—polycystic ovary syndrome	2.95e-05	0.000143	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—SLC2A4—polycystic ovary syndrome	2.94e-05	0.000142	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.91e-05	0.000141	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.87e-05	0.000139	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—INSR—polycystic ovary syndrome	2.83e-05	0.000137	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FGF18—polycystic ovary syndrome	2.82e-05	0.000137	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	2.82e-05	0.000137	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—RBP4—polycystic ovary syndrome	2.79e-05	0.000135	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CYP19A1—polycystic ovary syndrome	2.76e-05	0.000134	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PPARG—polycystic ovary syndrome	2.73e-05	0.000132	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—GNAS—polycystic ovary syndrome	2.7e-05	0.000131	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.69e-05	0.000131	CbGpPWpGaD
Minocycline—CYCS—Metabolism—POMC—polycystic ovary syndrome	2.69e-05	0.00013	CbGpPWpGaD
Minocycline—CYCS—Metabolism—INS—polycystic ovary syndrome	2.68e-05	0.00013	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.65e-05	0.000128	CbGpPWpGaD
Minocycline—IL1B—Immune System—IRS1—polycystic ovary syndrome	2.64e-05	0.000128	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PGR—polycystic ovary syndrome	2.62e-05	0.000127	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—YAP1—polycystic ovary syndrome	2.61e-05	0.000126	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GAB1—polycystic ovary syndrome	2.57e-05	0.000125	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.57e-05	0.000125	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NRG1—polycystic ovary syndrome	2.52e-05	0.000122	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GNAS—polycystic ovary syndrome	2.46e-05	0.000119	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—INSR—polycystic ovary syndrome	2.46e-05	0.000119	CbGpPWpGaD
Minocycline—IL1B—Immune System—AKT2—polycystic ovary syndrome	2.44e-05	0.000118	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GHRL—polycystic ovary syndrome	2.44e-05	0.000118	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PLAT—polycystic ovary syndrome	2.44e-05	0.000118	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—VEGFA—polycystic ovary syndrome	2.38e-05	0.000115	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—IL6—polycystic ovary syndrome	2.36e-05	0.000114	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—NCOR1—polycystic ovary syndrome	2.35e-05	0.000114	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.34e-05	0.000113	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ATF1—polycystic ovary syndrome	2.33e-05	0.000113	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—IL6—polycystic ovary syndrome	2.31e-05	0.000112	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.3e-05	0.000112	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PGR—polycystic ovary syndrome	2.28e-05	0.00011	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.27e-05	0.00011	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CYP1A1—polycystic ovary syndrome	2.22e-05	0.000108	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IRS2—polycystic ovary syndrome	2.16e-05	0.000105	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NGFR—polycystic ovary syndrome	2.15e-05	0.000104	CbGpPWpGaD
Minocycline—IL1B—Immune System—BCL2—polycystic ovary syndrome	2.13e-05	0.000103	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PRL—polycystic ovary syndrome	2.13e-05	0.000103	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PLAT—polycystic ovary syndrome	2.12e-05	0.000103	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GHRL—polycystic ovary syndrome	2.12e-05	0.000103	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—LEP—polycystic ovary syndrome	2.11e-05	0.000102	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—MTHFR—polycystic ovary syndrome	2.07e-05	0.000101	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ATF1—polycystic ovary syndrome	2.02e-05	9.79e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.02e-05	9.79e-05	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—IL6—polycystic ovary syndrome	2e-05	9.71e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.97e-05	9.55e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IRS1—polycystic ovary syndrome	1.89e-05	9.14e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GNAS—polycystic ovary syndrome	1.87e-05	9.08e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NGFR—polycystic ovary syndrome	1.86e-05	9.04e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PRL—polycystic ovary syndrome	1.85e-05	8.96e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—POMC—polycystic ovary syndrome	1.82e-05	8.8e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—INS—polycystic ovary syndrome	1.81e-05	8.75e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.78e-05	8.65e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL6—polycystic ovary syndrome	1.77e-05	8.57e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.75e-05	8.5e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NRG1—polycystic ovary syndrome	1.75e-05	8.49e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IGF1—polycystic ovary syndrome	1.75e-05	8.47e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—AKT2—polycystic ovary syndrome	1.75e-05	8.46e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PPARG—polycystic ovary syndrome	1.68e-05	8.15e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.66e-05	8.04e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—POMC—polycystic ovary syndrome	1.66e-05	8.04e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—INS—polycystic ovary syndrome	1.65e-05	8e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—IL6—polycystic ovary syndrome	1.65e-05	7.99e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GNAS—polycystic ovary syndrome	1.63e-05	7.88e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.55e-05	7.51e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NRG1—polycystic ovary syndrome	1.52e-05	7.37e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IRS2—polycystic ovary syndrome	1.5e-05	7.27e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—LEP—polycystic ovary syndrome	1.47e-05	7.11e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—IL6—polycystic ovary syndrome	1.43e-05	6.93e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IRS1—polycystic ovary syndrome	1.31e-05	6.35e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IRS2—polycystic ovary syndrome	1.3e-05	6.31e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—LEP—polycystic ovary syndrome	1.27e-05	6.18e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—POMC—polycystic ovary syndrome	1.26e-05	6.11e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—INS—polycystic ovary syndrome	1.25e-05	6.08e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IGF1—polycystic ovary syndrome	1.21e-05	5.88e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—AKT2—polycystic ovary syndrome	1.21e-05	5.87e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.15e-05	5.58e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.14e-05	5.53e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IRS1—polycystic ovary syndrome	1.14e-05	5.51e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL6—polycystic ovary syndrome	1.1e-05	5.36e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—POMC—polycystic ovary syndrome	1.09e-05	5.31e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—INS—polycystic ovary syndrome	1.09e-05	5.28e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IGF1—polycystic ovary syndrome	1.05e-05	5.1e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—AKT2—polycystic ovary syndrome	1.05e-05	5.1e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1e-05	4.85e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—VEGFA—polycystic ovary syndrome	7.92e-06	3.84e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IL6—polycystic ovary syndrome	7.89e-06	3.83e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL6—polycystic ovary syndrome	5.48e-06	2.66e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IL6—polycystic ovary syndrome	4.76e-06	2.31e-05	CbGpPWpGaD
